Akèy › Leksemi biphenotipik egi › Minnesota › Rochester
Etid klinik pou Leksemi biphenotipik egi nan Rochester, MN
3 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Mayo Clinic in Rochester, Rochester
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- Mayo Clinic in Rochester, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
Etid Leksemi biphenotipik egi nan lòt vil
- Seattle, WA15 etid
- Houston, TX11 etid
- New York City, NY10 etid
- Atlanta, GA9 etid
- Durham, NC8 etid
- Memphis, TN7 etid
- Chicago, IL7 etid
- Charlotte, NC6 etid
- Aurora, CO6 etid
- Baldwin Park, CA6 etid
- Portland, OR6 etid
- Los Angeles, CA6 etid
Lòt etid nan Rochester
- Kansè nan tete42 etid
- Kansè Poumon ki pa ti selil37 etid
- Kansè Metastatik31 etid
- Kansè (tout kalite)30 etid
- Kansè kolorektal29 etid
- Kansè ovè29 etid
- Myelom Miltip24 etid
- Kansè pwostat22 etid
- Ensifizyans kadyak22 etid
- Kansè pankreyas22 etid
- Kansè poumon20 etid
- Kansè Endomèt20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.